Clinical Trials
4
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (75.0%)Phase 1
1 (25.0%)Animal and Microbial-based Dietary Protein Efficiency in Adults
Not Applicable
Recruiting
- Conditions
- Protein Metabolism
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-08-29
- Lead Sponsor
- Daniel Moore
- Target Recruit Count
- 13
- Registration Number
- NCT07148908
- Locations
- 🇨🇦
Kinesiology & Physical Education, Toronto, Ontario, Canada
Influence of Leucine Enriched Amino Acids on Myofibrillar and Collagen Protein Synthesis
Not Applicable
Active, not recruiting
- Conditions
- Interventional
- First Posted Date
- 2022-09-26
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Daniel Moore
- Target Recruit Count
- 8
- Registration Number
- NCT05554653
- Locations
- 🇨🇦
Goldring Centre for High Performance Sport at the University of Toronto, Toronto, Ontario, Canada
Protein Requirements for Active Children
Not Applicable
Completed
- Conditions
- Increased Metabolic RequirementHealthy
- First Posted Date
- 2017-05-22
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- Daniel Moore
- Target Recruit Count
- 8
- Registration Number
- NCT03163043
- Locations
- 🇨🇦
Goldring Centre For High Performance Sport, Toronto, Ontario, Canada
Safety Study of Latanoprost Slow Release Insert
Phase 1
Terminated
- Conditions
- Ocular Hypertension (OHT)Primary Open Angle Glaucoma (POAG)
- Interventions
- First Posted Date
- 2010-08-11
- Last Posted Date
- 2014-12-08
- Lead Sponsor
- Daniel Moore
- Target Recruit Count
- 12
- Registration Number
- NCT01180062
- Locations
- 🇺🇸
Univ of Ky Dept of Ophthalmology and Visual Sciences, Lexington, Kentucky, United States
News
No news found